Normalization cancer immunotherapy: blocking Siglec-15!
Authors:
Open Access
- 19 April 2019
- journal article
- editorial
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 4 (1) , 1-2
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapyNature Medicine, 2019
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to NormalizationCell, 2018
- Primary, Adaptive, and Acquired Resistance to Cancer ImmunotherapyCell, 2017
- What does PD-L1 positive or negative mean?Journal of Experimental Medicine, 2016
- The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF- secretion from monocytes/macrophages through the DAP12-Syk pathwayGlycobiology, 2012